We’re Famous, Almost | Palm Connections and Mashable

Posted October 9th, 2010 by Michael G Stults with 3 Comments

Niemann-Pick Children’s Fund was featured on Mashable.com through Palm Connections. This is huge because literally thousands upon thousands aggregate news and read these publications. A few months back I ran across an opportunity on Facebook to submit an application to be apart of Palm Connections. They wanted to utilize technology and good causes in conjunction with one another to share with the world. I thought as I filled out that application there is no way out of thousands of applications we would be selected. Continue Reading

October is Niemann-Pick Disease Awareness Month 2010

Posted October 6th, 2010 by Michael G Stults with 1 Comment

October is Niemann-Pick Disease awareness month! Just wanted to pass along what many of you might be aware of if your connected in the NPC community. The below is directly from NNPDF’s site.

Please participate on 10-10-10 for a $10 donation online to the NNPDF. They are truly doing some great things and we are thankful to be able to have them around.

Take the NPD 10 – 10 – 10  Challenge!
Please Help Raise Awareness for Niemann-Pick Disease Continue Reading

MyDunkTank.com Dare By Steve Hugunin | Niemann-Pick Type C

Posted August 31st, 2010 by Michael G Stults with 1 Comment

Wednesday August 25th Steve Hugunin’s hair line changed forever. Well maybe just for another 30 days! He participated with MyDunkTank.com in raising money for the Niemann-Pick Children’s Fund in honor of my two sons Brisan and Parker Stults. He had two weeks to accomplish his mission. The dares were to shave his head, dress up in a DealBug.com costume for a month, and the other was to go skydiving because he is afraid of heights.

Continue Reading

What is Niemann-Pick Type C?

Posted June 9th, 2010 by Michael G Stults with 1 Comment

Orphan Drug Designation for Cyclodextrin | NPC

Posted May 23rd, 2010 by Michael G Stults with 1 Comment

This week the FDA has stated formally that they see promise in the use of Cyclodextrin in treating Niemann-Pick Type C (NPC) by granting its “Orphan Drug Designation”.

In January of 1983, the Orphan Drug Act (ODA) was passed into law in the United States with consistent pursuit by the National Organization for Rare Disorders. The ideal behind this is to encourage pharmaceutical companies to look into smaller markets with development of drugs for orphan diseases. Niemann-Pick Type C (NPC) certainly falls into this category (around than 500 diagnosed ever worldwide). The benchmark on how to determine an orphan disease is one that affects less than 200,000 people. Continue Reading

  • Sharing Is Caring

  • Donate

    Donate to the Niemann-Pick Children's Fund

  • Subscribe to our mailing list

    Email Format



    Subsribe to our Feed|Niemann-Pick Children's Fund


  • Post Tags

  • Twitter